News.

As part of our work, we have the privilege to speak with many inspiring innovators. Although the business community usually focuses on companies, pitches, and valuations—and less on the innovator—we thought it would be interesting to learn a bit more about the people behind healthcare innovation. This latest conversation is with Itai Hayut, CEO of Scopio Labs, which combines artificial intelligence with innovative imaging technology to analyze cell morphology at scale.

The First Ever Solution to Enable Digitization and Analysis of Full Field Peripheral Blood Smears with Decision Support System (DSS) Tailored to Augment Hematology Diagnostics. Scopio Labs, a leading provider of Full Field Morphology (FFM), announced today that it was granted FDA clearance to market and sell its X100 with Full Field Peripheral Blood Smear (Full Field PBS) Application, unlocking the potential of in vitro hematology diagnosis. Full Field PBS is also available in Europe with CE mark certification granted earlier this year.

Scopio Labs, a Tel Aviv-based start-up, is changing the field of microscopy as we know it through its machine learning-based digital microscopy system. It takes much more than an apple a day to keep the doctor away. These days, many of us are turning to tech to monitor and tend to our own health, thereby lessening the need for frequent visits to the doctor for regular checkups.

With $16 million in recently closed Series B funding, Israeli digital microscopy firm Scopio Labs is expanding its commercial operations including a planned US Food and Drug Administration submission for automated hematology diagnostics.

Scopio Labs, an advanced digital microscopy company, today announced it has completed a $16 million financing round, bringing its total funding to $30 million. The Series B round will enable Scopio Labs to expand commercial operations across human and veterinary care in the United States and Europe, by ramping up manufacturing and sales, and further developing a robust clinical trial pipeline to broaden its portfolio of offerings.

Scopio Labs, a company advancing digital microscopy, today announced it has received CE mark certification for its X100 Full Field Peripheral Blood Smear (Full Field PBS) all-digital morphology analysis platform. As the first digital microscope to scan and analyze entire regions of interest from a slide in high resolution, Full Field PBS enables remote consultation and includes a computer-vision based decision support system, advancing manual microscopy into the digital age.